Form 13F
SEC Filings
Form 13F is the quarterly disclosure that institutional investment managers overseeing at least $100 million file with the SEC, listing their U.S. equity holdings. It lets investors track which funds are building or exiting biotech positions.
Related terms
Track Form 13F across 1,000+ biotechs
BioSniper monitors FDA decisions, clinical trials, and catalysts in real time — with evidence-backed AI analysis.
Start Free